Your browser doesn't support javascript.
loading
The Potential of Intralesional Rose Bengal to Stimulate T-Cell Mediated Anti-Tumor Responses.
Maker, Ajay V; Prabhakar, Bellur; Pardiwala, Krunal.
Afiliación
  • Maker AV; Division of Surgical Oncology, Department of Surgery, University of Illinois at Chicago, Chicago Illinois, USA ; Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago Illinois, USA.
  • Prabhakar B; Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago Illinois, USA.
  • Pardiwala K; Division of Surgical Oncology, Department of Surgery, University of Illinois at Chicago, Chicago Illinois, USA.
J Clin Cell Immunol ; 6(4)2015 Aug.
Article en En | MEDLINE | ID: mdl-26618054
ABSTRACT
Rose Bengal (RB) is a red synthetic dye that was initially used in the garment industry and has been used safely for decades as a corneal stain by ophthalmologists. Antineoplastic properties of RB have also been observed, though the mechanism of action remained to be elucidated. Recently, interest in RB as a therapeutic cancer treatment has increased due to significant anti-tumor responses with direct tumor injection in human clinical trials for metastatic melanoma. In these patients, there has been the implication that RB may mount a T-cell mediated anti-tumor response and impart antigen-specific responses in distant bystander lesions. This article serves to evaluate the potential of intralesional rose bengal to stimulate T-cell mediated anti-tumor responses in in-vitro, pre-clinical, and clinical studies.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Clin Cell Immunol Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Clin Cell Immunol Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos